tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Compare Arcutis Biotherapeutics (ARQT) vs. Competitors

962 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arcutis Biotherapeutics
$23.27
$2.93B
62.73%
8 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$31.67
$2.92B
-67.82
108.77%
12 Buy
2 Hold
0 Sell
Strong Buy
Disc Medicine
$66.85
$2.55B
-13.21
70.54%
11 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$27.62
$1.60B
23.98
-2.75%
4 Buy
3 Hold
1 Sell
Moderate Buy
Tarsus Pharmaceuticals
$68.76
$2.93B
-51.51
44.79%
8 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$3.19
$1.69B
-2.84
-24.05%
1 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARQT
Arcutis Biotherapeutics
23.27
9.98
75.09%
TVTX
Travere Therapeutics
31.67
17.52
123.82%
IRON
Disc Medicine
66.85
32.57
95.01%
HRMY
Harmony Biosciences Holdings
27.62
-0.51
-1.81%
TARS
Tarsus Pharmaceuticals
68.76
24.13
54.07%
RXRX
Recursion Pharmaceuticals
3.19
-0.78
-19.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts